Patents Assigned to Revvity Health Sciences, Inc.
  • Patent number: 11940381
    Abstract: Methods for calibrating a multispectral analysis system include calibrating the system to detect fluorescence emission from a first fluorescent entity in a biological sample that includes the first fluorescent entity and a second fluorescent entity using a calibration sample, where the calibration sample features a first concentration of the first fluorescent entity and a second concentration of the second fluorescent entity, and where the first concentration is larger than the second concentration.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: March 26, 2024
    Assignee: Revvity Health Sciences, Inc.
    Inventors: Rongcong Wu, Daniel Schoener
  • Patent number: 11747495
    Abstract: Presented herein are systems and methods that provide for calibration and/or testing of liquid scintillation counters (LSCs) using an electronic test source. In certain embodiments, the electronic test source described herein provides for emission of emulated radioactive event test pulses that emulate light pulses produced by a scintillator as a result of radioactive decay of a variety of different kinds of radioactive emitters (e.g., beta, alpha, and gamma emitters). Additionally, in certain embodiments, the systems and methods described herein provide for the emission of emulated background light (e.g., luminescence and after-pulses) from the electronic test source. The emulated radioactive event test pulses and, optionally, emulated background light can be used for the calibration and/or testing of LSCs, in place of hazardous radioactive material and/or volatile chemicals.
    Type: Grant
    Filed: February 1, 2022
    Date of Patent: September 5, 2023
    Assignee: Revvity Health Sciences, Inc.
    Inventor: Richard Harazin